Maximum quantity allowed is 999
Please select the quantity
CAS RN: 609799-22-6 | Product Number: T3813
Tasimelteon
×
![]()
×
Purity: >95.0%(qNMR)
Synonyms:
- N-[[(1R,2R)-2-(2,3-Dihydro-4-benzofuranyl)cyclopropyl]methyl]propanamide
Product Documents:
| Size | Unit Price | Same Day | 2-3 Business Days | Other Lead Time |
Shipping Information
|
|---|---|---|---|---|---|
| 10MG |
₩158,000
|
6 | 1 | Contact Us | |
| 50MG |
₩555,800
|
2 | 14 | It can be shipped in about 2 weeks after ordering |
* Please contact our distributor of SEJIN CI Co., Ltd.
if you would like to purchase TCI products. The above prices do not include freight cost, customs charge and other charges to the destination. SEJIN CI Co., Ltd. (Phone: 02-2655-2480 / email:
sales@sejinci.co.kr)
* The storage conditions are subject to change without notice.
* The storage conditions are subject to change without notice.
| Product Number | T3813 |
Purity / Analysis Method 
|
>95.0%(qNMR) |
| Molecular Formula / Molecular Weight | C__1__5H__1__9NO__2 = 245.32 |
| Physical State (20 deg.C) | Solid |
| Storage Temperature
|
Refrigerated (0-10°C) |
| Condition to Avoid | Heat Sensitive |
| Packaging and Container
|
50MG-Glass Bottle with Plastic Insert (View image) |
| CAS RN | 609799-22-6 |
| Reaxys Registry Number | 15439325 |
| PubChem Substance ID | 468592958 |
| MDL Number | MFCD09033789 |
Specifications
| Appearance | White to Almost white powder to crystal |
| Purity(HPLC) | min. 98.0 area% |
| Purity(qNMR) | min. 95.0 % |
| Specific rotation [a]20/D | -41.0 to -46.0 deg(C=1, CHCL3) |
| NMR | confirm to structure |
Properties (reference)
| Melting Point | 78 °C |
| Specific Rotation | -45° (C=1,CHCl3) |
GHS
Related Laws:
| RTECS# | TX1450577 |
Transport Information:
| H.S.code* | 2932.99-000 |
Application
Tasimelteon: A Selective Melatonin MT1 and MT2 Receptors Agonist
Tasimelteon (BMS-214778) is a melatonin [M1105] receptor agonist with both high affinity for melatonin MT1 and MT2 receptors, similar to other members of the melatonin receptor agonist including ramelteon [R0216] and agomelatine [A2606]. Characteristically, tasimelteon exhibits a greater affinity for the MT2 as compared to the MT1 receptor. The agonist activity at the MT1 and MT2 receptors has been reported to contribute to its sleep-promoting properties. And then, tasimelteon currently is approved in the United States and the EU for the treatment of the treatment of non-24-hour sleep-wake disorder. (The product is for research purpose only.)
References
- Preclinical pharmacokinetics and metabolism of BMS-214778, a novel melatonin receptor agonist
- Tasimelteon, a melatonin agonist for the treatment of insomnia and circadian rhythm sleep disorders (a review)
- Tasimelteon: a selective and unique receptor binding profile
- Tasimelteon: first global approval (a review)
Product Articles
Product Documents (Note: Some products will not have analytical charts available.)
Safety Data Sheet (SDS)
Please select Language.
The requested SDS is not available.
Please Contact Us for more information.
Specifications
C of A & Other Certificates
Please enter Lot Number
Incorrect Lot Number. Please input only the 4-5 alphanumeric characters before the hyphen.
Sample C of A
This is a sample C of A and may not represent a recently manufactured lot of the product.
A sample C of A for this product is not available at this time.
Analytical Charts
Please enter Lot Number
Incorrect Lot Number. Please input only the 4-5 alphanumeric characters before the hyphen.
The requested analytical chart is not available. Sorry for the inconvenience.